XYNOS KONSTANTINOS (Chief Medical Officer) sold 4.9% of their position (7.25K shares) of REPLIMUNE GROUP, INC. on the open market
Open‑market sale worth $66.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/19/2025ACC: 0001104659-25-114122
Officer· Chief Medical Officer
Since Dec 2022
-7.25K
Net shares
Net seller
$66.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
7.25K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.25K
Price / share
$9.10
Trade value
$65.96K
% of position
4.9%
11/17/2025
146.93K→139.69K
Total
Net shares
−7.25K
Net value
-$65.96K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/17/2025 | S · Sale | −7.25K | $9.10 | $65.96K | 4.9% | 146.93K | 139.69K |
| Total | −7.25K | -$65.96K | ||||||
Derivative Transactions0
No derivative transactions reported